Nutrition plays a role in the management of atopic dermatitis, according to research presented at the American Academy of Dermatology Annual Meeting.“Conventional medicine, including dermatology, has ...

A high throughput screen of >30,000 diverse repressor domains from across the tree of life identifies repressor domains with unique structures that underpin enhanced epigenetic effector domain ...

Biotechnology company United Therapeutics (NASDAQ:UTHR) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.7% year on year to $735.9 million. Its GAAP profit of $6.19 per ...

Piotr Swat / SOPA Images / LightRocket via Getty Images Summit Therapeutics shares dropped 14% Monday as it reported a fourth-quarter adjusted loss nearly double that of the previous year.

ESCONDIDO, Calif.--(BUSINESS WIRE)--BTB Therapeutics, Inc., a clinical-stage drug development company developing a non-opioid pain medicine ENDOPIN, today announced the election of David R.

08:07 EST Summit Therapeutics (SMMT) jumps 5% to $23.19 after trial pact with Pfizer (PFE) See what stocks are receiving strong buy ratings from top-rated analysts. Filter, analyze, and streamline ...

Ark Invest, through its ARK Genomic Revolution ETF ARKG and ARK Innovation ETF ARKK, bought a total of 24,640 shares of Beam Therapeutics. This comes after the firm’s previous acquisition of ...

Viking Therapeutics (NASDAQ:VKTX) quickly soared 12% amid some renewed takeover speculation for the obesity drug maker. There's some renewed speculation Viking (NASDAQ:VKTX) may be a takeover ...

A rumor regarding Viking Therapeutics (VKTX) was highlighted in an alert sent to subscribers of Ben Harrington’s takeover-focused Betaville blog, contacts tell The Fly. Published first on TheFly ...